TIDMHIK

RNS Number : 1308R

Hikma Pharmaceuticals Plc

25 June 2020

TR-1: S tandard form for notification of major holdings

LONDON, 25 June 2020 - Hikma Pharmaceuticals PLC (LEI: 549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) (LSE: HIK) announces as follows:

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible) (i) 
 
 1a. Identity of the issuer or the                              Hikma Pharmaceuticals PLC (LEI: 549300BNS685UXH4JI75) 
  underlying issuer of existing shares 
  to which voting rights are attached 
  (ii) : 
                                                              -------------------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                                  ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                                        X 
                                                                                                                  ---- 
 An acquisition or disposal of financial instruments 
                                                                                                                  ---- 
 An event changing the breakdown of voting rights 
                                                                                                                  ---- 
 Other (please specify)(iii) : 
                                                                                                                  ---- 
 3. Details of person subject to the notification obligation (iv) 
 Name                                                          Boehringer Ingelheim Invest GmbH 
 City and country of registered office                         Ingelheim am Rhein, Germany 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.) (v) 
 Name                                                          N/A 
                                                              -------------------------------------------------------- 
 City and country of registered office                         N/A 
  (if applicable) 
                                                              -------------------------------------------------------- 
  5. Date on which the threshold was                           23 June 2020 
  crossed or reached (vi) : 
                                                                25 June 2020 
                                                              -------------------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):                25 June 2020 
                                                              -------------------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                             % of voting          % of voting rights        Total of both      Total number 
                            rights attached        through financial         in % (8.A +        of voting rights 
                           to shares (total           instruments                8.B)           of issuer (vii) 
                               of 8. A)              (total of 8.B 
                                                      1 + 8.B 2) 
                        ---------------------  -----------------------  --------------------  ------------------------ 
 Resulting situation        23 June 2020:                 0                 23 June 2020:           23 June 2020: 
  on the date             12,833,233 shares                               12,833,233 shares           12,833,233 
  on which threshold         bought back                                     bought back            shares bought 
  was crossed               by the issuer                                   by the issuer            back by the 
  or reached               with a resultant                               with a resultant           issuer with 
                             position of                                     position of             a resultant 
                               11.16%.                                         11.16%.               position of 
                            25 June 2020:                                   25 June 2020:            27,166,767. 
                         Remaining 27,166,767                                 Remaining             25 June 2020: 
                             shares sold                                     27,166,767          Remaining 27,166,767 
                             in a placing                                    shares sold             shares sold 
                           with a resultant                                 in a placing             in a placing 
                             position of                                  with a resultant         with a resultant 
                                 0%.                                         position of             position of 
                                                                                 0%.                      0. 
                        ---------------------  -----------------------  --------------------  ------------------------ 
 Position of 
  previous 
  notification 
  (if 
  applicable)                   16.67%                    0                    16.67% 
                        ---------------------  -----------------------  --------------------  ------------------------ 
 
 
 
 8. Notified details of the resulting situation on the date on which 
  the threshold was crossed or reached (viii) 
 A: Voting rights attached to shares 
 Class/type of        Number of voting rights                               % of voting rights 
  shares               (ix) 
  ISIN code (if 
  possible) 
                              Direct                    Indirect                     Direct                  Indirect 
                        (Art 9 of Directive        (Art 10 of Directive        (Art 9 of Directive     (Art 10 of Directive 
                            2004/109/EC)               2004/109/EC)           2004/109/EC) (DTR5.1)        2004/109/EC) 
                              (DTR5.1)                  (DTR5.2.1)                                          (DTR5.2.1) 
                                               -------------------------- 
                           23 June 2020: 
                         12,833,233 shares 
                            bought back                                          23 June 2020: 
                           by the issuer                                        12,833,233 shares 
                          with a resultant                                       bought back by 
                            position of                                          the issuer with 
                            27,166,767 .                                      a resultant position 
                           25 June 2020:                                           of 11.16%. 
                        Remaining 27,166,767                                      25 June 2020: 
                            shares sold                                       Remaining 27,166,767 
                            in a placing                                         shares sold in 
 Ordinary shares          with a resultant                                       a placing with 
  of 10 pence each          position of                                       a resultant position 
  (GB00B0LCW083)                 0.                         0                        of 0%.                     0 
                     ------------------------  --------------------------  -------------------------  --------------------- 
 SUBTOTAL 8. A                     23 June 2020: 27,166,767                              23 June 2020: 11.16% 
                                        25 June 2020: 0                                     25 June 2020: 0% 
                     ----------------------------------------------------  ------------------------------------------------ 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial    Expiration    Exercise/                        Number of voting                  % of voting 
  instrument           date          Conversion Period                rights that may                   rights 
                       (x)           (xi)                             be acquired if 
                                                                      the instrument 
                                                                      is 
                                                                      exercised/converted. 
                     ------------  -------------------------------  --------------------------------  --------------------- 
 N/A 
                      --------------------------------------------  --------------------------------  --------------------- 
 
 
                       SUBTOTAL 8. B 1 
                      --------------------------------------------  --------------------------------  --------------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of        Expiration          Exercise/              Physical or           Number of             % of voting 
  financial      date (x)            Conversion             cash                  voting rights         rights 
  instrument                         Period (xi)            settlement 
                                                            (xii) 
               ------------------  ---------------------  --------------------  -------------------- 
 N/A 
                                               ---------  --------------------  -------------------- 
 
 
                                                           SUBTOTAL 8.B.2 
                                                          --------------------  -------------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer (xiii) 
 Full chain of controlled undertakings through which the voting rights                        X 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity (xiv) (please add additional 
  rows as necessary) 
       Name (xv)           % of voting rights      % of voting rights       Total of both if 
                             if it equals or        through financial        it equals or is 
                            is higher than the      instruments if it        higher than the 
                           notifiable threshold    equals or is higher     notifiable threshold 
                                                   than the notifiable 
                                                        threshold 
                         ----------------------  ---------------------  ------------------------ 
 C.H. Boehringer 
  Sohn AG & Co. KG                  0                      0                        0 
                         ----------------------  ---------------------  ------------------------ 
 Boehringer Ingelheim 
  Corporate Center 
  GmbH                              0                      0                        0 
                         ----------------------  ---------------------  ------------------------ 
 Boehringer Ingelheim 
  Verwaltungs GmbH                  0                      0                        0 
                         ----------------------  ---------------------  ------------------------ 
 Boehringer Ingelheim 
  International GmbH                0                      0                        0 
                         ----------------------  ---------------------  ------------------------ 
 Boehringer Ingelheim 
  Auslandsbeteiligungs 
  GmbH                              0                      0                        0 
                         ----------------------  ---------------------  ------------------------ 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder                         N/A 
                                                 ----------------------------------------------- 
 The number and % of voting rights                N/A 
  held 
                                                 ----------------------------------------------- 
 The date until which the voting rights           N/A 
  will be held 
                                                 ----------------------------------------------- 
 
 11. Additional information (xvi) 
 None 
 
 
 
 Place of completion   Germany 
 Date of completion    Buyback by the issuer completed 23 June 2020. 
                        Sale in the placing completed 25 June 2020. 
                      ---------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUVAVRRRUNUAR

(END) Dow Jones Newswires

June 25, 2020 11:12 ET (15:12 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Lug 2020 a Ago 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Ago 2019 a Ago 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals